Steris (STE) EBIT Growth (3y) (2021 - 2026)
Steris (STE) EBIT Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.49 Bn | 193.88 Bn | 7.27 Bn | 3.16% |
| 2 | Stryker | 127.80 Bn | 124.32 Bn | 4.50 Bn | 19.80% |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn | 6.17% |
| 4 | Boston Scientific | 73.58 Bn | 73.04 Bn | 3.85 Bn | 31.84% |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 24.88% |
| 6 | Dexcom | 34.34 Bn | 32.39 Bn | 830.00 Mn | 35.44% |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.66 Bn | 2.18 Bn | 9.04% |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | 60.19% |
| 9 | Steris | 23.07 Bn | 22.59 Bn | 684.20 Mn | 13.06% |
| 10 | Zimmer Biomet Holdings | 19.23 Bn | 18.82 Bn | 1.54 Bn | -0.36% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 13.06% |
| Mar 31, 2026 | -24.91% |
| Dec 31, 2025 | 12.71% |
| Sep 30, 2025 | 42.07% |
| Jun 30, 2025 | 15.81% |
| Mar 31, 2025 | 14.47% |
| Dec 31, 2024 | 6.52% |
| Sep 30, 2024 | 23.55% |
| Jun 30, 2024 | 134.83% |
| Mar 31, 2024 | 916.76% |
| Dec 31, 2023 | 15.49% |
| Sep 30, 2023 | 10.68% |
| Jun 30, 2023 | 19.52% |
| Mar 31, 2023 | 68.02% |
| Dec 31, 2022 | 10.25% |
| Jun 30, 2022 | 432.84% |
| Mar 31, 2022 | 0.85% |
| Dec 31, 2021 | 42.87% |
| Sep 30, 2021 | 3.01% |
| Jun 30, 2021 | -46.67% |